Clinic
Suresh Gupta MD INC
Suresh Gupta MD INC was paid $8.41M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
33Billing provider infoSURESH GUPTA MD INC
DAYTON, OH 45432
DAYTON, OH 45432
33aNPI1508895640assigned 07/01/2006
33bProvider typePain Clinic/Center
28Total paid$8.41M
24GClaims230,395
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Clinic/Center providers in Ohio
Rank by total paid#1 of 8
Median peer was paid$239K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 52,928 | $1.10M | |
| 2019 | 49,813 | $1.19M | |
| 2020 | 48,352 | $1.20M | |
| 2021 | 24,359 | $1.33M | |
| 2022 | 20,486 | $1.18M | |
| 2023 | 17,750 | $1.32M | |
| 2024incomplete | 16,707 | $1.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 44,854 | 41,249 | $1.92M |
| 36475 | 18% | 1,447 | 849 | $1.53M | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 15% | 9,898 | 9,347 | $1.25M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.0% | 16,155 | 15,401 | $674K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.3% | 20,759 | 19,105 | $611K |
| 93970 | 6.1% | 4,929 | 4,470 | $514K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.9% | 2,241 | 2,144 | $159K |
| 64635 | 1.5% | 2,373 | 2,008 | $127K | |
| 80346 | 1.5% | 5,580 | 5,439 | $126K | |
| 80364 | 1.3% | 5,581 | 5,440 | $108K | |
| 64493 | <1% | 2,542 | 2,174 | $84K | |
| 80321 | <1% | 5,580 | 5,439 | $76K |
38 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,552 | $68K |
| 80336 | <1% | 5,580 | $61K | |
| 80331 | <1% | 5,579 | $61K | |
| 80357 | <1% | 5,581 | $60K | |
| 80355 | <1% | 5,583 | $60K | |
| 80366 | <1% | 5,581 | $60K | |
| 80370 | <1% | 5,581 | $60K | |
| 80345 | <1% | 5,580 | $60K | |
| 80326 | <1% | 5,580 | $60K | |
| 80375 | <1% | 5,568 | $60K | |
| 80358 | <1% | 5,581 | $60K | |
| 80353 | <1% | 5,579 | $60K | |
| 80349 | <1% | 5,581 | $60K | |
| 80354 | <1% | 5,579 | $60K | |
| 80359 | <1% | 5,579 | $60K | |
| 64483 | <1% | 1,515 | $54K | |
| 64494 | <1% | 2,525 | $45K | |
| 64636 | <1% | 2,383 | $42K | |
| 62323 | <1% | 599 | $36K | |
| 81002 | <1% | 14,911 | $26K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,487 | $22K |
| 97113 | <1% | 942 | $21K | |
| 27096 | <1% | 311 | $19K | |
| 97162 | <1% | 448 | $17K | |
| 20552 | <1% | 306 | $6K | |
| 62321 | <1% | 92 | $6K | |
| 64495 | <1% | 293 | $5K | |
| 20610 | <1% | 139 | $4K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 114 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 94 | $2K |
| 64490 | <1% | 28 | $1K | |
| 20553 | <1% | 26 | $714.83 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 32 | $522.47 |
| 64491 | <1% | 28 | $520.96 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 149 | $486.33 |
| 64484 | <1% | 12 | $414.94 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 150 | $258.20 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 208 | $221.44 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUPTA, SAPNA (CHIEF LEGAL OFFICER)